Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2000
10/05/2000CA2364622A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000CA2359652A1 Novel prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of peripheral vascular disease and pulmonaryhypertension
10/05/2000CA2291286A1 Chitosan-containing soft capsule and process for producing the same
10/04/2000EP1041149A2 Vaccine and antitoxin for treatment and prevention of C. difficile disease
10/04/2000EP1040838A1 Stable aqueous EM 12 solution
10/04/2000EP1040832A1 Creams containing vitamin d 3? derivatives
10/04/2000EP1040828A1 Water-base liquid preparation
10/04/2000EP1040823A2 Stable foam compositions
10/04/2000EP1040822A1 Extensible Mask with an adhesive matrix which is at least stretchable when wetted
10/04/2000EP1040122A1 Protein binding polypeptides
10/04/2000EP1039933A2 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS
10/04/2000EP1039932A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
10/04/2000EP1039922A1 Improved interferon polymer conjugates
10/04/2000EP1039921A1 Substantially pure histidine-linked protein polymer conjugates
10/04/2000EP1039920A1 Fatty acid-acylated insulin analogs
10/04/2000EP1039909A1 Method and composition of an oral preparation of itraconazole
10/04/2000EP1039908A1 Molecular dispersion composition with enhanced bioavailability
10/04/2000EP1039905A1 Pharmaceutical formulation comprising glycine as a stabilizer
10/04/2000EP1039898A1 Compositions comprising cannabinoids
10/04/2000EP1039880A1 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
10/04/2000EP1039874A1 Compositions and methods for treatment of alopecia
10/04/2000EP1039843A1 Biodegradable intra vaginal devices
10/04/2000EP0690719B1 Dry mix formulation for bisphosphonic acids
10/04/2000EP0619731B1 Microcrystalline cellulose spheronization composition
10/04/2000EP0575581B1 Novel cocaine derivatives and protein and polypeptide cocaine derivative conjugates and labels
10/04/2000CN1269013A Moleculars withch give out multiple active parts
10/04/2000CN1268378A Injection capable of raising immunity of fowl and livestock and makig their meat, egg and milk into health-care products
10/04/2000CN1056973C Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it
10/03/2000US6127425 A solution of tamoxifen citrate and a mixture of ethanol, a glycol, e.g. propylene glycol, glycerol, and water; high concentration to be the equivalent of solid dosage of tasmoxifen; crystallization inhibition; complexes-free
10/03/2000US6127355 High molecular weight polymer-based prodrugs
10/03/2000US6127349 For increasing the water solubility and bioavailability of pharmaceutical agents by conjugation to phospholipids
10/03/2000US6127348 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/03/2000US6127339 Peptide for binding thereto a low density lipoprotein
10/03/2000US6127334 Mixing acidic solution of insulin, zinc, and a sub-isophanic amount of protamine with an alkaline solution of a physiological buffer; where one solution contains a phenolic compound, to form suspension, leaving to form phases
10/03/2000US6127170 Multifunctional complexes for gene transfer into cells comprising a nucleic acid bound to a polyamine and having a endosome disruption agent
10/03/2000US6127126 Detection or tumors in brain cells; screening for nucleotide sequences that code mutant proteins, detecting tumors in sample
10/03/2000US6126971 Stable oral CI-981 formulation and process for preparing same
10/03/2000US6126969 Immediate release/sustained release compressed tablets
10/03/2000US6126966 Liposomes containing a cisplatin compound
10/03/2000US6126964 Making a complex for delivery to a cell, forming a polymer from monomers in the presence of polyion for delivery to cells
10/03/2000US6126962 Crystalline powdery saccharide, its preparation and uses
10/03/2000US6126960 Oral compositions having enhanced mouthfeel
10/03/2000US6126959 Pharmaceutical composition for treating dysmenorrhea and premature labor
10/03/2000US6126951 Silicone-free carbon based replacements for the volatile cyclomethicones.
10/03/2000US6126946 Hepatocyte-selective oil-in-water emulsion
10/03/2000US6126936 Microcapsules and composite microreactors for immunoisolation of cells
10/03/2000US6126920 Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition
10/03/2000US6126919 Metered dose inhaler for sustained release
10/03/2000CA2206463C Silicone compositions
10/03/2000CA2172664C Interferon solution
10/03/2000CA2117046C Liposomal antibiotic formulation
10/03/2000CA2115065C Ultrafine particle powder for inhalation and method for production thereof
10/03/2000CA2006953C Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids.
10/03/2000CA2000336C Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
09/2000
09/30/2000CA2303570A1 Stable foam compositions
09/30/2000CA2302886A1 A stable aqueous solution of em 12
09/28/2000WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof
09/28/2000WO2000056774A1 Methods of using bioelastomers
09/28/2000WO2000056773A1 Antibodies specific for cyp1b1
09/28/2000WO2000056726A1 Improved aqueous solubility pharmaceutical formulations
09/28/2000WO2000056370A1 Methods for inhibiting the formation of endoleaks associated with endovascular repair of abdominal aortic aneurysms
09/28/2000WO2000056367A1 Hemoglobin-antioxidant conjugates
09/28/2000WO2000056366A1 Gel-microemulsion formulations
09/28/2000WO2000056365A1 Use of trehalose for stabilising a liquid vaccine
09/28/2000WO2000056364A1 Propofol formulation containing tris
09/28/2000WO2000056362A2 Polycationic carbohydrates as immunostimulants in vaccines
09/28/2000WO2000056361A2 Vaccine composition
09/28/2000WO2000056357A2 Staphylococcus antigen and vaccine
09/28/2000WO2000056346A1 Stable oil-in-glycerin emulsion
09/28/2000WO2000056342A2 Use of stabilised oligonucleotides for preparing a medicine with antitumour activity
09/28/2000WO2000056338A1 Quinazoline formulations and therapeutic use thereof
09/28/2000WO2000056336A2 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin
09/28/2000WO2000056325A2 Ibuprofen solution
09/28/2000WO2000056291A1 Pharmaceutical solubilized in aerosol propellant
09/28/2000WO2000056290A1 Transdermal therapy system and method for producing the same
09/28/2000WO2000056289A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
09/28/2000WO2000056288A1 Nanoparticles, complexes with polynucleotides and their use
09/28/2000WO2000056284A2 Potentiation medium
09/28/2000WO2000056282A1 Particle based vaccine composition
09/28/2000WO2000056281A1 Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained
09/28/2000WO2000056280A1 Non-stinging coating composition
09/28/2000WO2000056251A1 Cell-culture and polymer constructs
09/28/2000WO2000056153A1 Oral low dose butyrate compositions
09/28/2000WO2000045878A3 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor
09/28/2000WO2000042973A3 Homing pro-apoptotic conjugates and methods of using same
09/28/2000WO2000041740A3 Particles for oral delivery of peptides and proteins
09/28/2000WO2000041481A3 Medicament forms having controlled release and containing active substances which easily dissolve in water
09/28/2000WO2000033822A9 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
09/28/2000WO2000023592A9 Minimal promoters and uses thereof
09/28/2000WO2000023114A3 Polymer conjugates of interferon beta- 1a and their uses
09/28/2000WO2000016808A3 Antibody directed enzyme prodrug therapy (edept) with glucoronidase
09/28/2000WO2000013712A3 Methods and compositions for the prevention or treatment of cancer
09/28/2000DE19913732A1 Nikotin-TTS mit einem Zusatz von Monoterpenketonen Nicotine TTS with an addition of monoterpene ketones
09/28/2000DE19913692A1 Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen Mechanically stable pharmaceutical dosage forms containing liquid or semisolid surface-active substances
09/28/2000DE19913640A1 Pharmaceutical composition comprising drug, e.g. anticancer agent, encapsulated in liposomes, containing polymer-lipid conjugate as stabilizer to inhibit liposome aggregation
09/28/2000DE19913606A1 Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen Powdered Solubilisationshilfsstoffe for solid pharmaceutical dosage forms
09/28/2000DE19913333A1 Use of hyperforin for treating cancer, or in topical compositions optionally together with hypericin for treating e.g. inflammatory skin disease, skin aging or bacterial skin infections
09/28/2000DE19912933A1 Potenziermedium Potenziermedium
09/28/2000DE19912623A1 Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile A method for increasing the stability during storage and / or application of light-sensitive therapeutic systems or components thereof
09/28/2000DE19912477A1 Self-adhesive transdermal therapeutic system for e.g. drug or hormone delivery, comprises an active agent deposit and a connected matrix, including a paper substrate
1 ... 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 ... 1712